FAZLA KİLOLU VE OBEZ ADÖLESANLARDA METABOLİK SENDROM SIKLIĞI İLE KARDİYOVASKÜLER RİSK FAKTÖRLERİNİN DEĞERLENDİRİLMESİ

Amaç: 5-19 yaş arası 340 milyonun üzerinde fazla kilolu veya obez olduğu bildirilmiştir. Çocukluk çağı veadölesan dönemde başlayan obezite, metabolik sendrom ve kardiyovasküler hastalıklara zemin hazırlamakta,aterosklerotik sürecin hızlanmasına neden olmaktadır. Çalışmamızın amacı aşırı kilolu ve obez adölesanlardakardiyovasküler hastalıklar için risk faktörlerini ve metabolik sendrom sıklığını değerlendirmektir. Materyal ve Metot: Çalışma popülasyonu 11-18 yaş arası fazla kilolu ve obez adölesanlardan oluşmaktadır.Katılımcıların antropometrik ölçümleri ve kan örneklerini aldıktan sonra REGODCI puanlama sistemine görekardiyovasküler riskleri ve Uluslararası Diyabet Federasyonu'na göre metabolik sendrom prevalanslarıincelenmiştir. Bulgular: Çalışmaya 150 fazla kilolu ve obez adölesan dahil edildi. Katılımcıların 115’i (%76,70) obez idi;%22'sinde (n=33) Metabolik sendrom (MetS); %46,60'ında (n=80) kardiyometabolik risk (KMR) varlığısaptandı. MetS tanısı alan katılımcıların vücut kitle indeksleri (VKİ), sistolik kan basıncı, TG-HDL oranlarıarasında istatistiksel olarak anlamlı fark saptandı (sırasıyla p = 0,040, p= 0,012 ve p

EVALUATION OF RISK FACTORS FOR CARDIOVASCULARDISEASES AND PREVALENCE OF METABOLICSYNDROME IN OVERWEIGHT AND OBESEADOLESCENTS

Objectives: It is reported that there are more than 340 million people who are either overweight or obese aged between 5-19. Obesity starting in childhood and adolescence leads up to metabolic syndrome, cardiovascular diseases and hastens the atherosclerotic process. The aim of our study is to evaluate risk factors for cardiovascular diseases and the prevalence of metabolic syndrome in overweight and obese adolescents.Materials and Methods: The study population comprised overweight and obese adolescents aged 11–18 years. After taking all anthropometric measurements and blood samples; cardiovascular risk according to the REGODCI scoring system and prevalence of metabolic syndrome according to the International Diabetes Federation were examined. Results: 150 overweight and obese adolescents were included. 115 (76.70%) subjects were determined as obese. MetS was seen in 22% (n=33); cardiometabolic risk (CMR) was seen in 46.60% (n=80) of the participants. A statistically significant difference between systolic blood pressure, TG/HDL, and BMI of participants diagnosed with MetS was detected (p = 0.040, p= 0.012, p < 0.001, respectively). A significant correlation was found between CMR and participants’ BMI, TG/HDL, waist-hip ratio (p = 0.001, p = 0.001, p= 0.034, respectively). According to the ROC analysis for MetS, the area under the curve was 0.826, the cutoff value was 2.59 with 72% sensitivity and 72% specificity; and for the CMR the area under the curve was 0.652, the cutoff value was 2.06 with 65% sensitivity and 63% specificity.Conclusion: Obesity is an independent risk factor for both MetS and CMR, and it should be treated immediately after diagnosis. TG/HDL ratio may use as a predictor factor for MetS (over 2.59) and for CMR (over 2.06) in overweight and obese adolescents.

PDF

___

1. World Health Organization, Obesity and overweight key facts [Internet] https://www.who.int/newsroom/fact-sheets/detail/obesity-and-overweight. (Accessed: 04.04.2020).
2. Türkiye endokrinoloji ve metabolizma derneği, Metabolik sendrom kılavuzu. [Turkey endocrinology and metabolism association, Metabolic syndrome guide]. [Internet]. http://temd.org.tr/admin/uploads/tbl_yayinlar/metabolik_sendrom.pdf. (Accessed: 04.04.2020).
3. Raj M. Obesity and cardiovascular risk in children and adolescents. Indian J Endocrinol Metab 2012;16(1):13-9.
4. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000;314:1–27.
5. Hatipoglu N, Ozturk A, Mazicioglu M, Kurtoğlu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7 to 17 year-old Turkish children and adolescents. Eur J Pediatr 2008;167(4):383-9.
6. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-73.
7. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007;8(5):299-6.
8. Sovio U, Skow A, Falconer C, Park MH, Viner RM, Kinra S. Improving prediction algorithms for cardiometabolic risk in children and adolescents. J Obes 2013;2013:684782.
9. Tamir I, Heiss G, Glueck CJ, Christensen B, Kwiterovich P, Rifkind B. Lipid and lipoprotein distributions in white children ages 6–19 yrs: the Lipid Research Clinics Program Prevalence Study. J Chronic Dis 1981;34(1):27–39.
10. Yucel BB, Toprak D. Evaluation of anthropometric and biochemical parameters in obese children between 6-16 years. Ankara Med J 2016;16(1):27-40.
11. T.C. Sağlık Bakanlığı (TR). Türkiye obezite (şişmanlık) ile mücadele ve kontrol programı. [Struggle with obesity and control program in Turkey] Ankara: Sağlık Bakanlığı Yayın No: 773; 2011.
12. Akac H, Babaoglu K, Hatun S, Aydogan M, Turker G, Gokalp AS. Kocaeli bölgesindeki okul çağı çocuklarında obezite ve risk faktörleri. Pediatr J 2002;2(1):29-2.
13. Guney C. Assessment of moderation effect of personality traits on the relationship between body image and social anxiety among adolescents aged between 15-18 years. Ph.D. Thesis, Isık University Institute of Social Sciences, Department of Clinical Psychology, Istanbul; 2018.
14. Al-Agha AE, Mahjoub AO. Impact of body mass index on high blood pressure among obese children in the western region of Saudi Arabia. Saudi Med J 2018;39(1):45-1.
15. Shi Y, de Groh M, Morrison H. Increasing blood pressure and its associated factors in Canadian children and adolescents from the Canadian Health Measures Survey. BMC Public Health 2012;12(1):388-8.
16. Ozer S, Sonmezgoz E. Frequency of metabolic syndrome and its components in obese children. J of the Child 2015;15(1):10-5.
17. Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children–a systematic review. Arch Dis Child 2012;97(1):116-7.
18. Sangun O, Dundar B, Kosker M, Pirgon O, Dundar N. Prevalence of metabolic syndrome in obese children and adolescents using three different criteria and evaluation of risk factors. J Clin Res Ped Endo 2011;3(2)70–6.
19. Inanc BB. Metabolic syndrome in school children in Mardin, South-Eastern of Turkey. Eurasian J Med 2014;46(3):156–63.
20. Marzuillo P, Miraglia del Giudice E, Santoro N. Pediatric fatty liver disease: role of ethnicity and genetics. World J Gastroenterol 2014;20:7347–55.
21. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr 2013;162:496-500.
22. Ugras M, Kucuk O, Bicer S, Vitrinel A. Non alcoholic fatty liver disease in children. Bozok Med J 2014;4(1):55-61.
23. Jayawardene WP, Lohrmann D, Dickinson S, Talagala S, Torabi M. Clinical measures of obesity and cumulative cardiometabolic risk in adolescents. Clin Obes 2016;7(1):11-1.
24. Blüher S, Molz E, Wiegand S, et al. Adiposity patients registry initiative and the German competence net obesity. Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 2013;98(8):3384-93.
25. Sogut E, Avcı E, Ustuner F, Arikan E. The evaluation of (TG/HDL-C) ratio as a serum atherogenic Index. Turk J Biochem 2006;4:1-8.
26. Giorgis T, Marcovecchio ML, Giovanni I, et al. Triglycerides-to-HDL ratio as a new marker of endothelial dysfunction in obese prepubertal children. Eur. J. Endocrinol 2014;170(2):173–80.
27. Mohammadi F, Qorbani M, Kelishadi R, et al. Association of cardiometabolic risk factors and hepatic enzymes in a national sample of Iranian children and adolescents: the CASPIAN-III study. J. Pediatr. Gastroenterol. Nutr 2014;58(4):463-8.
28. Labayen I, Ruiz JR, Ortega FB, et al. Liver enzymes and clustering cardiometabolic risk factors in European adolescents: the HELENA study. Pediatr Obes 2015;10(5):361-70.
29. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119(4):628-47.
30. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52(5):1210-4.